CVN-417 | Interleukin Related interleukin-related.com

Product Name :
CVN-417

Search keywords :
CVN417

drugId :
null

Target Vo:
Neuronal acetylcholine receptor subunit alpha-6

Target Vo Short Name :
CHRNA6

Moa_Name:
Neuronal acetylcholine receptor subunit alpha-6 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Cerevance Ltd

Active Company_Name :
Aragen Lifesciences Ltd

Active Indication_Name:
Parkinson Disease

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
GSK3 beta Antibody (YA744)
BRAF Antibody
Ki-67 Antibody: Ki-67 Antibody is an unconjugated, approximately 358 kDa, rabbit-derived, anti-Ki-67 polyclonal antibody. Ki-67 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, background without labeling.

Author: Interleukin Related

Related Posts